基于单克隆抗体的治疗

单克隆抗体疗法在医药领域发挥着日益重要的作用，为各种疾病提供了靶向和精准的治疗方案。为确保这些疗法的成功实施，构建坚实的基础设施与资源体系不可或缺。 我们将带您深入了解那些能够加速单克隆抗体研发进程的创新解决方案，并探索推动该领域持续进步与发展的前沿分析技术、过程自动化工具及质量控制解决方案。

无论您是科研先锋、制药行业的精英，还是对单克隆抗体开发的复杂性充满好奇的探索者，该网页内容都是您的首选资源。让我们深入了解单克隆抗体的世界，共同探索为创新并高效的治疗方法铺设坚实基石的解决方案！

我们的团队随时为您提供帮助

请简单介绍一下您或您的组织希望实现的目标。
我们的专家将尽快与您联系。

参考文献

The Nobel Prize. The Nobel Prize in Physiology or Medicine 2018 – press release. (2018). https://www.nobelprize.org/prizes/medicine/2018/press-release/. 2. The Nobel Prize. The Nobel Prize in Physiology or Medicine 1984 – press release. (1984).

The Nobel Prize. The Nobel Prize in Physiology or Medicine 1984 – press release. (1984). https://www.nobelprize.org/prizes/medicine/1984/press-release/.

Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: Understanding time lags in translational research. J R Soc Med. 2011;104(12):510-520. doi:10.1258/JRSM.2011.110180

PhRMA. (2016). Modernizing Drug Discovery, Development and Approval. Accessed February 9, 2024. https://phrma.org/en/resource-center/Topics/Research-and-Development/Modernizing-Drug-Discovery-Development-and-Approval.

Alhazmi HA, Albratty M. Analytical Techniques for the Characterization and Quantification of Monoclonal Antibodies. J Pharm. 2023;16(2). doi:10.3390/PH16020291.

European Medicines Agency. (2023). ICH guideline Q14 on analytical procedure development. Accessed February 12, 2024. https://www.ema.europa.eu/en/ich-q14-analytical-procedure-development-scientific-guideline.

World Health Organization. (2022). Guidelines for the production and quality control of monoclonal antibodies and related products intended for medicinal use. Accessed February 12, 2024. https://www.who.int/publications/m/item/guideline-for-the-safe-production-and-quality-control-of-monoclonal-antibodies.

US Food & Drug Administration. (2023). Current Good Manufacturing Practice (CGMP) Regulations. Accessed February 12, 2024. https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations.

European Medicines Agency. Good manufacturing practice. (2023). Accessed February 12, 2024. https://www.ema.europa.eu/en/human-regulatory-overview/research-and-development/compliance-research-and-development/good-manufacturing-practice.

Sifniotis V, Cruz E, Eroglu B, Kayser V. Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation. Antibodies 2019, Vol 8, Page 36. 2019;8(2):36. doi:10.3390/ANTIB8020036.

Wolf B, Piksa M, Beley I, et al. Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity. Immunology. 2022;166(3):380-407. doi:10.1111/IMM.13481.